Indonesia’s healthcare sector plays a crucial role in safeguarding the well-being of its people and communities. However, with a population of over 270 million spread across thousands of islands, ensuring equitable access to healthcare services is a significant challenge.
Indonesia’s healthcare industry needs more healthcare talents. The issue is that there are more medical graduates than available job opportunities in the healthcare sector, even in cities. Hospitals then exploit this supply and demand disparity to hire doctors as cheaply as possible to maximise profits, making this more unattractive for local graduates.
Existing doctors work double-triple shifts in multiple places, which can also result in stress and burnout. Many also choose to fly abroad and find better-paying jobs outside the country, resulting in doctor shortage issues in second and thirdtier regions. This condition has an impact on the fulfilment of health talents to build this country’s health landscape to be on par with other developed countries and neighbouring countries in Southeast Asia (SEA).
According to the Ministry of Health of the Republic of Indonesia (MoH), the country requires over 160,000 doctors. At the same time, one of the healthcare reforms planned by the Minister, Budi Gunadi Sadikin, revolves around healthcare talent, among five others, in the 2020-2024 Digital Transformation Strategy. The strategy aims to transform the healthcare system into a more efficient, effective, patient-centred model.
In strengthening and improving healthcare talent, the MoH has also extensively supported health education through multiple scholarship programmes, which aim to support the equitable distribution of health workers. In the future, the government expects that all Indonesian provinces will have essential health services, such as heart disease treatments, by 2024.
هذه القصة مأخوذة من طبعة BioSpectrum Asia June 2023 من BioSpectrum Asia.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة BioSpectrum Asia June 2023 من BioSpectrum Asia.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time
US-based Promega Corporation, a life-sciences research partner dedicated to providing intuitive tools that empower scientists to innovate, has unveiled the new GloMax Galaxy Bioluminescence Imager.
Singleron and Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers
Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India.
Eppendorf brings CO2 incubator shaker with integrated 180 °C sterilisation routine
Eppendorf has announced the launch of a CO2 incubator shaker with integrated 180 °C sterilisation routine.
Waters introduces new bioseparations tools to improve development of RNA-based vaccines using LC-MS analysis
US-based Waters Corporation has introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify sequence and modification confirmation of large molecule RNA therapeutics using liquid chromatography-mass spectrometry (LCMS) analysis.
Singapore designs novel gene therapy offering hope for epilepsy patients
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore are working on a therapy that holds potential in treating patients with epilepsy, a neurological disorder defined by recurring seizures due to abnormal brain activity.
Spider venom heart drug moves to clinical trials in Australia
A University of Queensland (UQ)-led project in Australia to develop the first-ever drug to treat heart attack and protect donor hearts will move to human clinical trials, after receiving $17.8 million in funding from the Medical Research Future Fund (MRFF).
India develops portable ultrasound scanner for sports injury diagnosis
A team of researchers at the Indian Institute of Technology Madras (IIT-M) has developed an indigenous portable Point-of-CareUltrasound (POCUS) Scanner for sports injury diagnosis and management.
Integris appoints medtech veteran Probir Das as new CEO
Integris Healthcare, a global diversified medical technology company, has announced the appointment of Probir Das as Chief Executive Officer (CEO). He will join effective November 2024 and will be based in New Delhi.
Clarity Pharma promotes Michelle Parker to CEO
Australia-based Clarity Pharmaceuticals has announced the appointment of Michelle Parker as Chief Executive Officer (CEO), effective from October 11, 2024.
Dr Makoto Sugita steps in as President of Nxera Pharma Japan
Nxera Pharma Co., formerly known as Sosei Group or Sosei Heptares, has announced the appointment of Dr Makoto Sugita, as President of Nxera Pharma Japan, and Executive Officer, Executive Vice President and Chief Medical Officer (CMO) of Nxera Pharma.
